| Literature DB >> 36233520 |
Bosik Kang1, Jungyo Suh1, Bumjin Lim1, Kun Suk Kim1, Sang Hoon Song1.
Abstract
We investigated factors that affect the surgical outcomes of robotic pyeloplasty by comparing the surgical results of pediatric and adult patients with ureteropelvic junction stricture (UPJO). We retrospectively reviewed patients who underwent robotic pyeloplasty for UPJO between January 2013 and February 2022. The patients were categorized into two groups: the pediatric (≤18 years) and adult (>18 years) groups. The perioperative and postoperative outcomes and surgical complications were comparatively analyzed. Prognostic factors for predicting surgical failure were analyzed with multivariable logistic regression analysis. The pediatric group showed longer total operation and console times. The mean pain score was lower in the pediatric group than in the adult group on days 1 and 2 after surgery. The average amount of morphine used in the pediatric group was lower during postoperative days 0-2. No differences in the length of hospital stay, incidence of surgical failure, and incidence of urolithiasis requiring treatment after robotic pyeloplasty were observed between the groups. The only factor that predicted surgical failure was a history of urolithiasis before surgery. The results showed that age did not affect the surgical outcome.Entities:
Keywords: robotic pyeloplasty; ureteropelvic junction obstruction; urolithiasis
Year: 2022 PMID: 36233520 PMCID: PMC9570754 DOI: 10.3390/jcm11195651
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Port placement in right side (A) and left side (B) surgeries. The camera port was placed in the supraumbilical area with an 8, 8.5, or 12 mm port (red circle). The robotic arm ports were placed at the subxiphoid and lower abdominal areas (blue circles). An assistant port was placed at the suprapubic area (green circle).
Figure 2Port placement in 10-months-old infant with ureteropelvic junction obstruction on the left side. Three 8 mm robotic arm ports are placed in the abdomen. Subxiphoid and left lower abdominal areas are the robotic arm ports for left and right hands. Camera port is inserted on the supraumbilical area. Suprapubic 5 mm port is used as an assistant port.
Figure 3Surgical procedure of right RALP with crossing vessel. Renal pelvis (‘RP’), ureter (‘U’) and crossing vessel (‘C’) were observed (A). An anchoring stitch of renal pelvis is being made using 2-0 nylon suture (B). Dissection of renal pelvis and longitudinal ureter incision using scissors (C). Ureter anastomosis between renal pelvis and ureter was performed using 5-0 polyglyconate and 5-0 or polygalactin suture (D). Antegrade DJ stent was indwelled (E). Anterior wall anastomosis (F).
Patient demographics according to age groups.
| Pediatric Group | Adult Group | |
|---|---|---|
| Age at surgery, med (range), (year) | 7.5 (0–18) | 39.3 (19–74) |
| Height at surgery, med (range), (cm) | 122.5 (62.4–183.7) | 166.0 (149.3–186.8) |
| Weight at surgery, med (range), (kg) | 32.4 (7.1–110.3) | 63.3 (46.8–96.0) |
| Body mass index, med (range), (kg/m2) | 18.7 (12.8–35.6) | 22.9 (16.7–31.1) |
| * Obesity at surgery (%) | 13 (27.1) | 15 (21.7) |
| Gender (male:female) | 34:14 (70.8:29.2) | 31:38 (44.9:55.1) |
| Laterality (right:left) | 13:35 (27.1:72.9) | 28:41 (40.6:59.4) |
| s-Creatinine at surgery, med (range), (mg/dL) | 0.5 (0.2–1.5) | 0.9 (0.5–1.6) |
| SFU grade at surgery, | ||
| 1–2 | 2 (4.2) | 9 (13.0) |
| 3–4 | 46 (95.8) | 60 (87.0) |
| APPD at surgery, med (range), (cm) | 3.5 (0.7–6.7) | 4.1 (1.0–9.4) |
| SRF at surgery, med (range), (%) | 41.8 (5.5–56.6) | 36.5 (6.4–58.0) |
| No. presentation (%) | ||
| Prenatally detected | 17 (35.4) | 0 |
| Incidentally detected | 3 (6.3) | 19 (27.5) |
| Flank/abdominal pain | 20 (41.7) | 47 (68.1) |
| Gross hematuria | 5 (10.4) | 1 (1.4) |
| UTI | 3 (6.3) | 2 (2.9) |
| Pyeloplasty method (%) | ||
| Dismembered | 45 (93.8) | 69 (100) |
| Nondismembered | 3 (6.3) | 0 (0) |
| Surgical Approach (%) | ||
| Transmesenteric | 22 (45.8) | 16 (23.2) |
| Nontransmesenteric | 26 (54.2) | 53 (76.8) |
Continuous and categorical variables were expressed as means ± standard deviations and n (%), respectively. * Obesity = either one’s weight percentiles by height > 95 (in children) or BMI > 25 (in adult); s-Creatinine, serum creatinine; SFU, Society for Fetal Urology; APPD, anteroposterior pelvic diameter; SRF, split renal function; UTI, urinary tract infection.
Perioperative and postoperative outcomes according to age.
| Pediatric Group | Adult Group | ||
|---|---|---|---|
| Total operative time, median (range), (min) | 171 (70–324) | 148 (65–370) | 0.030 |
| Console time, median (range), (min) | 126 (78–220) | 110 (86–170) | 0.020 |
| Anastomosis time, median (range), (min) | 63 (15–100) | 45 (32–65) | 0.271 |
| Etiology, | 0.169 | ||
| Intrinsic-primary | 29 (60.4) | 34 (49.3) | |
| Intrinsic-polyp | 6 (12.5) | 5 (7.2) | |
| Crossing vessel | 13 (27.1) | 30 (43.5) | |
| Postoperative SRF, median (range), (%) | 41.7 (11.6–57.5) | 38.9 (12.0–59.8) | 0.418 |
| Postoperative s-Creatinine, median (range), (mg/dL) | 0.5 (0.2–1.1) | 0.8 (0.5–1.6) | 0.859 |
| Hospital day, median (range), (day) | 3.7 (2–12) | 4.7 (3–13) | 0.278 |
| Pain score ≥ 4 requires analgesics (%) | |||
| Postop day 0 | 17 (35.4) | 46 (66.7) | 0.648 |
| Postop day 1 | 4 (8.3) | 23 (33.3) | <0.001 |
| Postop day 2 | 1 (2.1) | 4 (5.8) | 0.049 |
| Morphine dose, median (range), (mg/kg) | |||
| Postop day 0 | 0.08 (0–0.25) | 0.15 (0–0.27) | 0.005 |
| Postop day 1 | 0.08 (0–0.33) | 0.24 (0–0.40) | 0.007 |
| Postop day 2 | 0.03 (0–0.30) | 0.11 (0–0.46) | 0.024 |
SRF, spilt renal function.
Comparison of the surgical complication outcomes according to age.
| Pediatric Group | Adult Group | ||
|---|---|---|---|
| Surgical complication * | 3 | 2 | 0.688 |
| Postoperative DJ insertion due to obstruction | 1 | 0 | |
| Ureteroscopic DJ removal due to DJ malposition | 1 | 0 | |
| DJ reposition due to DJ malposition at POD#1 | 1 | 0 | |
| Idiopathic hypoxia after surgery | 0 | 1 | |
| RIRS for recurred renal stone removal | 0 | 1 | |
| Secondary procedures needed | 3 | 3 | 0.688 |
| Surgical failure (%) | 2 (4.2) | 2 (2.9) | >0.999 |
| Redo pyeloplasty (%) | 0 (0.0) | 1 (1.4) | |
| Aggravation of hydronephrosis (%) | 1 (2.1) | 1 (1.4) | |
| Decrease in SRF in 36 months (%) | 1 (2.1) | 0 (0.0) | |
| Urolithiasis after pyeloplasty (%) | 3 (6.3) | 2 (2.9) | 0.400 |
| ESWL (%) | 2 (4.2) | 1 (1.4) | |
| RIRS (%) | 1 (2.1) | 1 (1.4) | |
| Urinary tract infection within 30 days after surgery | 3 | 0 | 0.066 |
* Clavien–Dindo classification grade ≥3; DJ, double J catheter; POD#1, postoperative day 1; SRF, spilt renal function; ESWL, extracorporeal shock wave lithotripsy; RIRS, retrograde intrarenal surgery.
Logistic regression analysis of the risk factors for surgical failure.
| Univariate | Multivariable | |||||
|---|---|---|---|---|---|---|
| Odds | 95% CI | Odds | 95% CI | |||
| * Obesity | 10.6 | 1.1–106.0 | 0.045 | * | * | 0.104 |
| Preop stone | 14.8 | 1.5–150.5 | 0.022 | 14.5 | 1.4–147.3 | 0.022 |
| ** Age (pediatric = 1) | 1.5 | 0.2–10.7 | 0.712 | |||
| *** Preop APPD | 1.0 | 0.5–1.8 | 0.965 | |||
| SRF (<30%) | 0.9 | 0.09–9.4 | 0.960 | |||
* Obesity = either one’s weight percentiles by height > 95 (in children) or BMI > 25 (in adults). ** The pediatric group (age ≤ 18) was used as a reference value. *** Anteroposterior pelvic diameter was processed as a continuous variable. APPD, anteroposterior pelvic diameter; SRF, spilt renal function; CI, confidence interval.
Figure 4Cosmetic outcomes of robot-assisted laparoscopic pyeloplasty. One month after surgery in infant (A) and one year after surgery in infant (B). One month after surgery in adult (C).